Poscale 100 Tablet contains Posaconazole 100 mg, a broad-spectrum triazole antifungal agent that inhibits fungal ergosterol synthesis, disrupting cell membrane formation and effectively controlling fungal growth. It is widely used in prevention and treatment of invasive fungal infections in high-risk patients.
Clinically, Poscale 100 Tablet is indicated for immunocompromised patients, hematological malignancies, stem cell transplant recipients, and individuals at risk of Aspergillus or Candida infections. Its potent antifungal action helps reduce morbidity and improves outcomes in patients susceptible to systemic fungal infections.
The tablet formulation ensures consistent bioavailability, precise dosing, and reliable therapeutic effects, making it suitable for hospitals, oncology centers, hematology clinics, and specialty pharmacies. Oral administration allows for convenient dosing and patient-friendly adherence.
Poscale 100 Tablet also contributes to infection prevention in high-risk patients, reduction of fungal burden, and faster recovery from systemic infections. Its evidence-based formulation makes it a safe, effective, and trusted antifungal therapy for managing serious and invasive fungal conditions.